সকল ফার্মেসি পণ্য রংপুর জেলার তামান্না ফার্মেসি থেকে সরবরাহ করা হয়

GLIPITA M 50/1000MG

Availability :
Out Of Stock

Product Code : 103119660500101

Short Description

GLIPITA M combines glipizide and metformin to control blood sugar in type 2 diabetes patients.

Name Brand Generic Name Strength PPF Price
GLIPITA M 50/1000MG Beximco Pharmaceuticals Ltd. SITAGLIPTIN+METFORMIN 50/1000mg TABLET 18
৳ 18
Qty :

Description

রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন

Indications:
GLIPITA M 50/1000MG is indicated for treatment of type 2 diabetes mellitus, particularly when diet, exercise, and monotherapy are insufficient to achieve adequate glycemic control.

Pharmacology:
GLIPITA M combines two antidiabetic agents: glipizide, a sulfonylurea that stimulates pancreatic insulin secretion, and metformin, a biguanide that decreases hepatic glucose production and improves insulin sensitivity.

Dosage:
Dosage must be individualized. Typically taken twice daily with meals to reduce gastrointestinal side effects. Dose adjustments depend on glycemic response and patient tolerance.

Administration:
Oral use, swallowed whole with water preferably during or after meals to minimize GI upset.

Interaction:
Possible interactions with other antidiabetics, diuretics, corticosteroids, beta-blockers, and alcohol which can affect blood glucose control.

Contraindications:

  • Type 1 diabetes mellitus

  • Diabetic ketoacidosis

  • Severe renal or hepatic impairment

  • Hypersensitivity to glipizide, metformin, or their excipients

Side Effects:

  • Hypoglycemia (due to glipizide)

  • Gastrointestinal disturbances (due to metformin) like nausea, vomiting, diarrhea

  • Weight gain

  • Rare lactic acidosis (metformin)

  • Allergic reactions

Pregnancy & Lactation:
Use only if clearly needed under medical supervision. Limited safety data available; insulin preferred during pregnancy.

Precautions & Warnings:

  • Monitor blood glucose and renal function regularly

  • Avoid alcohol consumption

  • Use caution in patients with liver or kidney disease

  • Stop before surgery or contrast imaging involving iodine to prevent lactic acidosis

Therapeutic Class:
Oral hypoglycemic agent – Combination of sulfonylurea and biguanide

Storage Conditions:
Store in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep out of reach of children.